F2RL1 and respiratory system disorder: The PAR2 modulators derived from GB88 have great potential for treating inflammatory and respiratory disorders through suppression of inflammatory cytokines secretion such as TNF-α and IL-6, induced by PAR2 agonists, in human kidney tubule epithelial cells (30).